AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER
Jun 242013
 

File:Linagliptin.png

LINAGLIPTIN

Phase III studies show linagliptin improved blood glucose control in Asian
Wall Street Journal
RIDGEFIELD, Conn. and INDIANAPOLIS, June 22, 2013 /PRNewswire/ — Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced results from two phase III clinical studies that showed linagliptin in Asian adults, as

READ ALL AT

http://online.wsj.com/article/PR-CO-20130622-901315.html

 

Share

  One Response to “Phase III studies show linagliptin improved blood glucose control in Asian …”

Sorry, the comment form is closed at this time.

Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: